218 related articles for article (PubMed ID: 19706537)
1. In vivo internal tumor illumination by telomerase-dependent adenoviral GFP for precise surgical navigation.
Kishimoto H; Zhao M; Hayashi K; Urata Y; Tanaka N; Fujiwara T; Penman S; Hoffman RM
Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14514-7. PubMed ID: 19706537
[TBL] [Abstract][Full Text] [Related]
2. Visualization of intrathoracically disseminated solid tumors in mice with optical imaging by telomerase-specific amplification of a transferred green fluorescent protein gene.
Umeoka T; Kawashima T; Kagawa S; Teraishi F; Taki M; Nishizaki M; Kyo S; Nagai K; Urata Y; Tanaka N; Fujiwara T
Cancer Res; 2004 Sep; 64(17):6259-65. PubMed ID: 15342413
[TBL] [Abstract][Full Text] [Related]
3. Tumor-selective, adenoviral-mediated GFP genetic labeling of human cancer in the live mouse reports future recurrence after resection.
Kishimoto H; Aki R; Urata Y; Bouvet M; Momiyama M; Tanaka N; Fujiwara T; Hoffman RM
Cell Cycle; 2011 Aug; 10(16):2737-41. PubMed ID: 21785265
[TBL] [Abstract][Full Text] [Related]
4. Improved Resection and Outcome of Colon-Cancer Liver Metastasis with Fluorescence-Guided Surgery Using In Situ GFP Labeling with a Telomerase-Dependent Adenovirus in an Orthotopic Mouse Model.
Yano S; Takehara K; Miwa S; Kishimoto H; Hiroshima Y; Murakami T; Urata Y; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
PLoS One; 2016; 11(2):e0148760. PubMed ID: 26849435
[TBL] [Abstract][Full Text] [Related]
5. Targeting tumors with a killer-reporter adenovirus for curative fluorescence-guided surgery of soft-tissue sarcoma.
Yano S; Miwa S; Kishimoto H; Uehara F; Tazawa H; Toneri M; Hiroshima Y; Yamamoto M; Urata Y; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
Oncotarget; 2015 May; 6(15):13133-48. PubMed ID: 26033451
[TBL] [Abstract][Full Text] [Related]
6. Selective metastatic tumor labeling with green fluorescent protein and killing by systemic administration of telomerase-dependent adenoviruses.
Kishimoto H; Urata Y; Tanaka N; Fujiwara T; Hoffman RM
Mol Cancer Ther; 2009 Nov; 8(11):3001-8. PubMed ID: 19887549
[TBL] [Abstract][Full Text] [Related]
7. Enhanced antitumor efficacy of telomerase-selective oncolytic adenoviral agent OBP-401 with docetaxel: preclinical evaluation of chemovirotherapy.
Fujiwara T; Kagawa S; Kishimoto H; Endo Y; Hioki M; Ikeda Y; Sakai R; Urata Y; Tanaka N; Fujiwara T
Int J Cancer; 2006 Jul; 119(2):432-40. PubMed ID: 16477640
[TBL] [Abstract][Full Text] [Related]
8. In vivo imaging of lymph node metastasis with telomerase-specific replication-selective adenovirus.
Kishimoto H; Kojima T; Watanabe Y; Kagawa S; Fujiwara T; Uno F; Teraishi F; Kyo S; Mizuguchi H; Hashimoto Y; Urata Y; Tanaka N; Fujiwara T
Nat Med; 2006 Oct; 12(10):1213-9. PubMed ID: 17013385
[TBL] [Abstract][Full Text] [Related]
9. Intraperitoneal administration of telomerase-specific oncolytic adenovirus sensitizes ovarian cancer cells to cisplatin and affects survival in a xenograft model with peritoneal dissemination.
Takakura M; Nakamura M; Kyo S; Hashimoto M; Mori N; Ikoma T; Mizumoto Y; Fujiwara T; Urata Y; Inoue M
Cancer Gene Ther; 2010 Jan; 17(1):11-9. PubMed ID: 19662088
[TBL] [Abstract][Full Text] [Related]
10. Fluorescence-guided assessment of bone and soft-tissue sarcomas for predicting the efficacy of telomerase-specific oncolytic adenovirus.
Uotani K; Tazawa H; Hasei J; Fujiwara T; Yoshida A; Yamakawa Y; Omori T; Sugiu K; Komatsubara T; Kondo H; Morita T; Kiyono M; Yokoo S; Hata T; Kunisada T; Takeda K; Urata Y; Fujiwara T; Ozaki T
PLoS One; 2024; 19(2):e0298292. PubMed ID: 38377118
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells.
Watanabe T; Hioki M; Fujiwara T; Nishizaki M; Kagawa S; Taki M; Kishimoto H; Endo Y; Urata Y; Tanaka N; Fujiwara T
Exp Cell Res; 2006 Feb; 312(3):256-65. PubMed ID: 16356494
[TBL] [Abstract][Full Text] [Related]
12. Adenoviral targeting of malignant melanoma for fluorescence-guided surgery prevents recurrence in orthotopic nude-mouse models.
Yano S; Takehara K; Kishimoto H; Urata Y; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
Oncotarget; 2016 Apr; 7(14):18558-72. PubMed ID: 26701857
[TBL] [Abstract][Full Text] [Related]
13. In vivo imaging of human cancer with telomerase-specific replication-selective adenovirus.
Fujiwara T
Methods Mol Biol; 2012; 872():129-39. PubMed ID: 22700408
[TBL] [Abstract][Full Text] [Related]
14. Eradication of osteosarcoma by fluorescence-guided surgery with tumor labeling by a killer-reporter adenovirus.
Yano S; Miwa S; Kishimoto H; Urata Y; Tazawa H; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
J Orthop Res; 2016 May; 34(5):836-44. PubMed ID: 26479501
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence-guided surgery of a highly-metastatic variant of human triple-negative breast cancer targeted with a cancer-specific GFP adenovirus prevents recurrence.
Yano S; Takehara K; Miwa S; Kishimoto H; Tazawa H; Urata Y; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
Oncotarget; 2016 Nov; 7(46):75635-75647. PubMed ID: 27689331
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Cell-Cycle-Decoy Efficacy of a Telomerase-Dependent Adenovirus in an Orthotopic Model of Chemotherapy-Resistant Human Stomach Carcinomatosis Peritonitis Visualized With FUCCI Imaging.
Yano S; Takehara K; Tazawa H; Kishimoto H; Urata Y; Kagawa S; Fujiwara T; Hoffman RM
J Cell Biochem; 2017 Nov; 118(11):3635-3642. PubMed ID: 27171483
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of detecting viable circulating tumour cells in gastric cancer patients using a telomerase-specific viral agent: a prospective study.
Ito H; Inoue H; Sando N; Kimura S; Gohda K; Sato J; Murakami K; Ito S; Odaka N; Satodate H; Kudo SE
BMC Cancer; 2012 Aug; 12():346. PubMed ID: 22873704
[TBL] [Abstract][Full Text] [Related]
18. Experimental Curative Fluorescence-guided Surgery of Highly Invasive Glioblastoma Multiforme Selectively Labeled With a Killer-reporter Adenovirus.
Yano S; Miwa S; Kishimoto H; Toneri M; Hiroshima Y; Yamamoto M; Bouvet M; Urata Y; Tazawa H; Kagawa S; Fujiwara T; Hoffman RM
Mol Ther; 2015 Jul; 23(7):1182-1188. PubMed ID: 25896244
[TBL] [Abstract][Full Text] [Related]
19. Enhanced oncolysis by a tropism-modified telomerase-specific replication-selective adenoviral agent OBP-405 ('Telomelysin-RGD').
Taki M; Kagawa S; Nishizaki M; Mizuguchi H; Hayakawa T; Kyo S; Nagai K; Urata Y; Tanaka N; Fujiwara T
Oncogene; 2005 Apr; 24(19):3130-40. PubMed ID: 15735729
[TBL] [Abstract][Full Text] [Related]
20. OBP-401-GFP telomerase-dependent adenovirus illuminates and kills high-metastatic more effectively than low-metastatic triple-negative breast cancer in vitro.
Yano S; Takehara K; Kishimoto H; Tazawa H; Urata Y; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
Cancer Gene Ther; 2017 Feb; 24(2):45-47. PubMed ID: 28106046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
